DM0000: The mark consists of the wording "BACHEM" in stylized form above the wording "PIONEERING PARTNER FOR PEPTIDES" in stylized form.
GS0051: Pharmaceutical and veterinary products, namely, pharmaceutical preparations for use in the treatment of bleeding, premature labor, pulmonary hypertension, erectile disfunction, coronary syndromes, prostate cancer, endometriosis, central precocious puberty, uterine myoma, osteoporosis, hypercalcernia, Paget's disease, reflex sympathetic dystrophy, nocturnal enureses, central diabetes insipidus, polyuria, polydipsia, hemophilia A, von Willebrand disease, unstable angina, myocardial infarction, hypoglycemia, ovarian follicular cysts, cryptochism, breast cancer, growth hormone deficiency, acromegaly, carcinoid syndrome, thyrotrophic adenomas, diabetes II, VIPosmas, ulcer bleeding, hemorrhagic gastritis, postoperative pancreatic and duodenal fistulae, variceal hemorrhage, neurological diseases, rheumatic diseases, skin diseases, diseases of the intestinal tract, cancer, conjunctivitis, glaucoma, ocular hypertension, Parkinson's disease, transfusion-induced hemosiderosis, candidasis, dermatophytosis, pityriasis, congenital homocystinuria, hyperammonaemia, hepatic encephalopathy, ischemic heart disease, chorioretinal vascular disorders, hypertension, endema, insomnia, bipolar disorder, and schizophrenia; pharmaceutical preparations for use in the diagnosis of gastrinoma; veterinary preparations for use in the induction of ovulation in estrous mares, and reproduction control in dogs and cats; pharmaceutical preparations for use in the diagnosis of Cushing's syndrome, hypothalamic-pituitary-gonadal axis function, growth hormone deficiency, pancreatic exocrine dysfunction, gastrinoma, and adrenocortical insufficiency; dietetic food and substances for medical or veterinary use, namely, taste-modulating food additives in the nature of peptides for medical use, appetite suppressors for medical use; food supplements for humans and animals; fungicides; herbicides
CC0000: Color is not claimed as a feature of the mark.
GS0011: Chemicals for use in industry and science, namely, amino acids, peptides, reagents for peptide synthesis, amino acid derivatives, cytokines, enzyme inhibitors, enzyme substrates, growth factors, peptide substrates, all for use as scientific and laboratory research reagents in the field of medicine and molecular biology; pharmaceutical intermediates for use in the further manufacture of pharmaceuticals; chemical products used for preserving foodstuffs
Case File Event Statements
5/29/2014 - 10 years ago
1 - SN ASSIGNED FOR SECT 66A APPL FROM IBType:REPR
7/23/2014 - 10 years ago
7 - REFUSAL PROCESSED BY MPUType:RFRR
7/23/2014 - 10 years ago
8 - NON-FINAL ACTION MAILED - REFUSAL SENT TO IBType:RFCS
1/8/2015 - 10 years ago
11 - CORRESPONDENCE RECEIVED IN LAW OFFICEType:CRFA
5/30/2014 - 10 years ago
2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTEREDType:NWOS
6/3/2014 - 10 years ago
3 - APPLICATION FILING RECEIPT MAILEDType:MAFR
7/17/2014 - 10 years ago
4 - ASSIGNED TO EXAMINERType:DOCK
7/17/2014 - 10 years ago
5 - NON-FINAL ACTION WRITTENType:CNRT
7/18/2014 - 10 years ago
6 - NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEWType:RFCR
8/8/2014 - 10 years ago
9 - REFUSAL PROCESSED BY IBType:RFNT
1/8/2015 - 10 years ago
10 - TEAS RESPONSE TO OFFICE ACTION RECEIVEDType:TROA
1/8/2015 - 10 years ago
12 - TEAS/EMAIL CORRESPONDENCE ENTEREDType:TEME
1/9/2015 - 10 years ago
16 - EXAMINER'S AMENDMENT ENTEREDType:XAEC
1/9/2015 - 10 years ago
13 - EXAMINERS AMENDMENT -WRITTENType:CNEA
1/9/2015 - 10 years ago
14 - EXAMINERS AMENDMENT E-MAILEDType:GNEA
1/9/2015 - 10 years ago
15 - NOTIFICATION OF EXAMINERS AMENDMENT E-MAILEDType:GNEN
1/9/2015 - 10 years ago
17 - APPROVED FOR PUB - PRINCIPAL REGISTERType:CNSA
1/29/2015 - 10 years ago
18 - ASSIGNED TO LIEType:ALIE
2/18/2015 - 10 years ago
20 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILEDType:NONP
2/18/2015 - 10 years ago
21 - NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IBType:OP2R
2/18/2015 - 10 years ago
22 - NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IBType:OPNS
3/10/2015 - 10 years ago
24 - PUBLISHED FOR OPPOSITIONType:PUBO
3/10/2015 - 10 years ago
25 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILEDType:NPUB
5/26/2015 - 9 years ago
26 - REGISTERED-PRINCIPAL REGISTERType:R.PR
8/26/2015 - 9 years ago
27 - FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IBType:FICR
2/1/2019 - 6 years ago
31 - NEW REPRESENTATIVE AT IB RECEIVEDType:NREP
1/30/2015 - 10 years ago
19 - LAW OFFICE PUBLICATION REVIEW COMPLETEDType:PREV
3/6/2015 - 10 years ago
23 - NOTIFICATION PROCESSED BY IBType:GPNX
9/24/2015 - 9 years ago
28 - FINAL DISPOSITION PROCESSEDType:FIMP
9/24/2015 - 9 years ago
29 - FINAL DISPOSITION NOTICE SENT TO IBType:FICS
10/30/2015 - 9 years ago
30 - FINAL DECISION TRANSACTION PROCESSED BY IBType:FINO
9/22/2022 - 2 years ago
35 - INVALIDATION PROCESSEDType:INPC
9/22/2022 - 2 years ago
36 - TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IBType:INTS
10/24/2022 - 2 years ago
37 - TOTAL INVALIDATION PROCESSED BY THE IBType:INNT
11/1/2024 - 4 months ago
38 - DEATH OF INTERNATIONAL REGISTRATIONType:DETH
11/1/2024 - 4 months ago
39 - NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILEDType:DENA
8/10/2022 - 2 years ago
34 - TOTAL INVALIDATION OF REG EXT PROTECTION CREATEDType:INTR
5/26/2020 - 4 years ago
32 - COURTESY REMINDER - SEC. 71 (6-YR) E-MAILEDType:REM3